Health care

Rethinking How To Achieve Universal Health Care Coverage in the US

Solutions to expanding heath care coverage in the U.S. are often incremental and focus on mitigating market failures. In new research, Katherine...

For the FDA, Fewer Regulations Can Create Safer Products

The US Food and Drug Administration is tasked with protecting consumers from unsafe food and medical products. In new research, Parker Rogers...

How the Wrong Presumptions Led to the Wrong Conclusions in the United/Change Healthcare Merger

On Sept. 19, a federal judge approved UnitedHealth Group’s acquisition of Change Healthcare over the concerns of the U.S. Department of Justice....

The Fall of American Manufacturing and the Rise of Health Care

In an excerpt from his new book The Next Shift, University of Chicago historian Gabriel Winant explores how deindustrialization and the decline...

Who Bears the Cost of Administrative Problems in Health Care?

A new paper explores the resources consumed by the complicated billing process in health care and the process’ impact on patients’ access...

Plagues Upon the Earth: How Wealth Intersects With Mortality

Kyle Harper’s new book, Plagues Upon the Earth: Disease and the Course of Human History, shows that the story of disease is...

Challenges to Sound Global Governance for Health

In an excerpt from his new book, Global Health Security: A Blueprint for the Future, Lawrence O. Gostin examines the challenges and...

Competition Problems in Prescription Drug Market

Although not the sole cause of high prescription drug costs, abusive practices that distort competition contribute to the problem. Too many companies...

The Unchecked Market Power of the American Health Care System

Chicago Booth alumnus and retired health care consultant David W. Ennis responds to ProMarket’s recent coverage on antitrust and the US health...

The Covid-19 Pandemic Should Not Delay Actions to Prevent Anticompetitive Consolidation in US Health Care Markets

Harvard Business School professor Leemore Dafny lays out potential reforms to assist agencies in halting anticompetitive acquisitions and practices, and to preserve...

LATEST NEWS

AI For the Antitrust Regulator

Cary Coglianese lays out the potential, and the considerations, for antitrust regulators to use machine learning and artificial intelligence algorithms.

Creation over Time in Copyright and Patent

On May 18, the United States Supreme Court decided two intellectual property cases with two seemingly different results. A closer look, however, reveals a complimentary concern with the monopolistic power of first movers and how the legal system should enable innovation from second movers over time, writes Randy Picker.

ESG Standards’ Good, Bad and Ugly

The Stigler Center for the Study of the Economy and the State hosted a virtual event discussing the standards, metrics and disclosures of investments focused on Environmental, Social and Governance (ESG) goals. The following is a transcript of the event.

Reregulate.

Lee Hepner and William J. McGee respond to Clifford Winston’s ProMarket piece asserting that further deregulation of the airline industry would resolve problems in the industry. Instead, the authors claim a return to regulation would produce better results for travelers.

A World With Far Fewer Mergers

Brooke Fox and Walter Frick analyze research and ideas presented at the Stigler Center Antitrust and Competition Conference that question the value of mergers.